Source:http://linkedlifedata.com/resource/pubmed/id/10997327
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-10-3
|
pubmed:abstractText |
B-Chronic lymphocytic leukemia (B-CLL) is an example of a human malignancy caused by alterations in the pathways of programmed cell death. In this disease the anti-apoptotic protein, bcl-2, is overexpressed and may lead to the prolonged survival of a malignant CLL clone. In the present study we examined the expression of bcl-2 and bax, which has an antagonistic role against the function of bcl-2, in cells from CLL patients at different stages of the disease, by immunoblot analysis. A direct association between the stage of the disease and the level of bcl-2 in the patients' cells was observed. At stages A and B, 33% and 29% of patients, respectively, expressed high levels of bcl-2, as opposed to 80% of patients at stage C (p= 0.019). Bax level was not significantly associated with the stage of the disease, although patients at stage C had higher levels of bax. In this study we found a trend of association between bcl-2 and bax levels. Analysis including all patients revealed that 65% of the patients who expressed high levels of bcl-2 had high levels of bax (p = 0.058). Of patients in stage C, 45% expressed high levels of both bcl-2 and bax while 50% and 42% of patients at stages A and B had low levels of both proteins.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/BAX protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0902-4441
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
80-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10997327-Adult,
pubmed-meshheading:10997327-Aged,
pubmed-meshheading:10997327-Aged, 80 and over,
pubmed-meshheading:10997327-Female,
pubmed-meshheading:10997327-Humans,
pubmed-meshheading:10997327-Immunoblotting,
pubmed-meshheading:10997327-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:10997327-Leukocyte Count,
pubmed-meshheading:10997327-Lymphocytes,
pubmed-meshheading:10997327-Male,
pubmed-meshheading:10997327-Middle Aged,
pubmed-meshheading:10997327-Neoplasm Staging,
pubmed-meshheading:10997327-Proto-Oncogene Proteins,
pubmed-meshheading:10997327-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:10997327-bcl-2-Associated X Protein
|
pubmed:year |
2000
|
pubmed:articleTitle |
Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease.
|
pubmed:affiliation |
Division of Haematology, Rabin Medical Center, Petach-Tikva, Israel. aviramar@netvision.net.il
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|